wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37697125-284339F4-F203-4737-8181-E9ED2B58B81A
Q37697125-284339F4-F203-4737-8181-E9ED2B58B81A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37697125-284339F4-F203-4737-8181-E9ED2B58B81A
Is there a benefit of first- or second-line crizotinib in locally advanced or metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer? a meta-analysis.
P2860
Q37697125-284339F4-F203-4737-8181-E9ED2B58B81A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37697125-284339F4-F203-4737-8181-E9ED2B58B81A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b22b2ce07594188857cf7e185cbe1bef5b8a2ca9
P2860
Alectinib in Crizotinib-Refractory ALK-Rearranged Non-Small-Cell Lung Cancer: A Phase II Global Study.